Operating Profit Should be Invested into R&D by More Than 10%

Published: 2002-01-11 06:57:00

Updated: 2002-01-11 06:57:00

Kim Jeong-soo, president of Korea Pharmaceutical Manufacturers Association, stressed that the operating profit should be invested into R&D by more than 10% for development of local pharmaceutical manufacturing industry, and the management pressure of pharmaceutical manufacturing companies should ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK